Orexigen Therapeutic (OREX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OREX | AZN | AMGN | GILD | VRTX |
| Company | Orexigen Therapeutic | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.25 | 90.37 | 321.21 | 122.00 | 454.28 |
| High | 0.32 | 91.52 | 324.74 | 122.98 | 454.62 |
| Low | 0.22 | 90.12 | 319.06 | 120.01 | 449.48 |
| Latest | 0.22 | 91.54 | 324.90 | 120.08 | 454.48 |
| Change | -0.12 | +1.71 | +7.16 | +0.47 | +2.44 |
| % Change | -34.41% | +1.90% | +2.25% | +0.39% | +0.54% |
| Volume | 3,735,400 | 4,242,772 | 2,196,218 | 3,279,564 | 648,781 |
| 20-Day Average Volume | 2,308,280 | 5,688,853 | 2,799,496 | 6,882,363 | 1,357,912 |
| Previous Close | 0.34 | 89.83 | 317.74 | 119.61 | 452.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.47 | 90.71 | 333.38 | 123.97 | 438.42 |
| 20-Day Raw Stochastic | 4.24% | 53.17% | 32.73% | 13.20% | 75.53% |
| 20-Day Relative Strength | 32.36 | 59.01 | 51.30 | 46.74 | 59.58 |
| Weighted Alpha | -72.99 | +42.40 | +22.54 | +26.24 | +13.02 |
| Today's Opinion | N/A | 100% Buy | 72% Buy | 56% Buy | 56% Buy |
| Previous Opinion | N/A | 88% Buy | 72% Buy | 56% Buy | 40% Buy |
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.37% since 03/27/18 | +0.12% since 12/08/25 | +0.71% since 12/08/25 | -0.91% since 12/08/25 | +2.43% since 12/08/25 |
| Low | 0.17 on 03/28/18 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 0.39 on 04/02/18 | 91.66 on 12/10/25 | 324.40 on 12/15/25 | 123.74 on 12/11/25 | 456.00 on 12/12/25 |
| 1-Month | |||||
| %Chg | -81.57% since 03/02/18 | +2.57% since 11/14/25 | -3.93% since 11/14/25 | -3.95% since 11/14/25 | +3.57% since 11/14/25 |
| Low | 0.17 on 03/27/18 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 1.42 on 03/09/18 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -82.02% since 01/03/18 | +17.09% since 09/15/25 | +17.90% since 09/15/25 | +6.70% since 09/15/25 | +15.14% since 09/15/25 |
| Low | 0.17 on 03/27/18 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.60 on 02/22/18 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -89.17% since 10/03/17 | +22.80% since 06/13/25 | +9.58% since 06/13/25 | +9.19% since 06/13/25 | -0.59% since 06/13/25 |
| Low | 0.17 on 03/27/18 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 2.32 on 10/13/17 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,212 | 278,601,088 | 171,096,960 | 149,377,888 | 114,691,136 |
| Shares Outstanding, K | 18,890 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 33,710,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -24,520,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 18,900,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -20,830,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 2.46 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.35 on 11/13/17 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 05/08/18 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.76 | 14.51 | 15.04 | 29.13 |